Market Research Trends

The global non-small cell lung cancer market had a market value of US$ 10 billion in 2023 and is predicted to reach a market value of US$ 20 billion by 2033, growing at a CAGR of 7.2% from 2023 to 2033. Its rapid expansion can be attributed to an increasing patient population, the projected introduction of many treatments, and greater investment in NSCLC research and development by market participants. Non-small cell lung cancer, one of the most common kinds of lung cancer, reduces the lungs' ability to provide oxygen to the blood. Non-small cell lung cancer accounts for 80-85% of all lung cancer cases worldwide. The causes are passive smoking, active smoking, consuming polluted water, and being exposed to air pollution. It can, however, be treated with a variety of medicines such as immunotherapy, targeted therapy, and others. The two primary causes of non-small cell lung cancer are excessive tobacco intake and active participation in passive smoking. Long-term air pollution ...